Tracking: Log the date, site used, and any observations (redness, soreness, lumps)
Once available, cagrilintide may be particularly suitable for patients who experience significant GI side effects with GLP-1 medications, those seeking an alternative mechanism for appetite control, or as part of combination therapy for enhanced results
Gastrointestinal Cytoprotection Originally studied in gastric lesion models, BPC-157 showed protective effects on: Gastric mucosa Intestinal healing Ulcer repair Reference: Sikiric et al., 1993 Gastric mucosal protection PubMed: Experimentally Observed Benefits of BPC 157 Peptides Below are benefits observed in controlled experimental models
It's also necessary for cellular metabolism and the metabolism of amino acids and fatty acids
Steinert JR, Chernova T, Forsythe ID
The primary mechanism involves intrinsic factor binding in the stomach, while a secondary pathway allows small amounts to absorb through passive diffusion